Goldman Sachs has now erased the entirety of its July 14 earnings spike, with the stock closing Tuesday at $1,033 — a level that puts it 10% below the Street's mean price target and $119 below the post-earnings peak of $1,152 reached just two weeks ago.
The drift has accelerated. The July 27 stock report flagged a 6.6% gap to the $1,137 consensus. That gap has now widened to roughly 10% against the updated $1,140 mean target, purely because the stock has continued to slide. This week alone, GS fell nearly 5%, noticeably underperforming close peers. Morgan Stanley lost 2.2% on the week. Interactive Brokers shed 3.7%. Invesco dropped 2.3%. Goldman absorbed the heaviest blow in the group. The one outlier was Artisan Partners, which gained 4.3% — but Artisan trades on a different dynamic entirely. The sector-wide tone was risk-off, and GS wore more of it than most.
The analyst landscape has not moved materially since the post-earnings re-rating wave. The target distribution remains as stretched as ever — Wells Fargo's Mike Mayo holds an Overweight at $1,325, BofA's Ebrahim Poonawala has a Buy at $1,300, while JPMorgan's Kian Abouhossein sits at Neutral with a $955 target and HSBC, after upgrading to Hold from Reduce on July 21, anchors the low end at $995. Bulls point to the 35% year-over-year surge in investment banking revenue from Q2, a record M&A advisory period, and strong trading desk performance. Bears counter that Goldman still leans heavily on capital markets for revenue — volatile by nature — and that regulatory headwinds and any macro slowdown would hit this model harder than a retail-banking peer. The earnings quality argument has been made; the market's response has been to keep selling.
Short interest is low and shrinking — at just 2% of the free float, down 17% over the past month — so this is not a short-squeeze setup, and there is no crowded bearish bet to unwind. The borrow market confirms the same: availability is extraordinarily loose at roughly 9,700% of short interest, meaning lenders have nearly 180 million shares available against the 6.3 million currently borrowed. Cost to borrow has ticked up 38% on the week to 0.45%, but that is still a trivially cheap rate — no signal of any squeeze dynamic. Options are modestly more defensive than their 20-day average, with the put/call ratio at 0.89 versus a mean of 0.86 and a z-score just above one. That is a mild caution signal, not an extreme. The ORTEX short score of 32.4 has been drifting lower through the week, consistent with the broader picture: this is a stock being sold by longs, not attacked by shorts.
The factor profile offers one genuinely positive signal amid the price weakness. EPS momentum ranks in the 95th percentile on a 30-day basis and the 92nd on 90-day, and the EPS surprise score of 87 reflects a company that has consistently beaten estimates — consistent with the blowout Q2 that catalysed the initial 10% move. The forward EPS picture is less inspiring, ranking only in the 21st percentile for year-over-year increase, which may explain some of the post-earnings fade: the quarter was excellent in isolation, but the forward trajectory is not generating the same enthusiasm. The P/E multiple has compressed 2.0 turns over the past 30 days to 14.3x, tracking the stock lower. Price-to-book is 2.6x, also drifting down.
The next scheduled catalyst is the Q3 earnings release on October 13. Between now and then, the question is whether the $1,033 level — essentially the pre-earnings base — acts as support or becomes the new ceiling. The spread between the bears' $955 anchor and the bulls' $1,300–$1,325 targets is unusually wide for a company of this profile, and how that distribution narrows from here will say more about the stock's direction than the borrow market or options positioning currently do.
See the live data behind this article on ORTEX.
Open GS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
